Recruiting PHASE3 Steatohepatitis, Nonalcoholic

New treatment option for Steatohepatitis, Nonalcoholic

Official title Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis

ClinicalTrials.gov ID: NCT07265297

What this study is testing

What is Hydrochloroquine?

Hydrochloroquine is an investigational medicine, being studied as a potential treatment for steatohepatitis, nonalcoholic.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The goal of this clinical trial is to learn if drug hydroxychloroquine works to treat steatohepatitis in adults. It will also learn about the safety of drug hydroxychloroquine.
  • Phase 3: a large, late-stage study
  • You might receive a placebo (an inactive treatment) instead of the study drug.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Participants must be at least 18 years old.
  • Participants must be able to return for scheduled follow-up visits during specific time points within the 12-month study period.
  • Diagnosis of fatty liver confirmed by abdominal ultrasound or magnetic resonance imaging (MRI).
  • Evidence of hepatic inflammation for more than three months, indicated by alanine aminotransferase (ALT) \> 41 IU/L.

You likely can't join if

  • Participants younger than 18 years old.
  • Pregnant or breastfeeding women.
  • Active viral hepatitis, determined by serum HBV or HCV viral load.
  • Currently taking hydroxychloroquine (HCQ) for other medical conditions or indications.
  • Known history of hypersensitivity or severe adverse drug reaction to HCQ.
  • Presence of retinal maculopathy.

The study team makes the final eligibility decision.

Where it's taking place

  • Taipei, Taiwan, Taiwan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Taipei, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.